Christopher Heberlig
Director of Finance/CFO at KSQ Therapeutics, Inc.
Profile
Christopher Heberlig was the founder of Kiniksa Pharmaceuticals Ltd.
(founded in 2015) where he held the title of Chief Financial Officer & Executive Vice President.
He is currently the Chief Financial Officer at KSQ Therapeutics, Inc. Mr. Heberlig's former positions include Finance Director & Controller at Panacos Pharmaceuticals, Inc., Principal at EPIX Pharmaceuticals, Inc. and NetGenesis Corp., and Principal at PricewaterhouseCoopers LLP.
He was also the President & Chief Financial Officer at Organovo Holdings, Inc. from 2020 to 2021.
Mr. Heberlig received his undergraduate degree from St. Lawrence University and his MBA from Questrom School of Business.
Christopher Heberlig active positions
Companies | Position | Start |
---|---|---|
KSQ Therapeutics, Inc.
KSQ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology KSQ Therapeutics, Inc. develops and deploys precision functional genomics to discover therapies that transform patient lives. The company was founded by Tim Wang and is headquartered in Cambridge, MA. | Director of Finance/CFO | - |
Former positions of Christopher Heberlig
Companies | Position | End |
---|---|---|
ORGANOVO HOLDINGS, INC. | Director of Finance/CFO | 07/05/2021 |
KINIKSA PHARMACEUTICALS, LTD. | Founder | 20/03/2020 |
SYNAGEVA BIOPHARMA CORP | Corporate Officer/Principal | 01/01/2015 |
PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Corporate Officer/Principal | - |
NetGenesis Corp.
NetGenesis Corp. Packaged SoftwareTechnology Services NetGenesis provides e-metrics through a combination of software and analytic consulting. E-Metrics are key performance indicators that combine online behavior with operational metrics to measure the effectiveness of online initiatives. | Corporate Officer/Principal | - |
Training of Christopher Heberlig
St. Lawrence University | Undergraduate Degree |
Questrom School of Business | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 3 |
---|---|
PANACOS PHARMACEUTICALS, INC. | Health Technology |
KINIKSA PHARMACEUTICALS, LTD. | Health Technology |
ORGANOVO HOLDINGS, INC. | Health Technology |
Private companies | 5 |
---|---|
EPIX Pharmaceuticals, Inc.
EPIX Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology EPIX Pharmaceuticals, Inc. used to develop targeted contrast agents both to improve the capability and expand the use of magnetic resonance imaging (MRI) as a tool for diagnosing human disease. The company was founded in 1988 and was headquartered in Lexington, MA. | Health Technology |
PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Commercial Services |
NetGenesis Corp.
NetGenesis Corp. Packaged SoftwareTechnology Services NetGenesis provides e-metrics through a combination of software and analytic consulting. E-Metrics are key performance indicators that combine online behavior with operational metrics to measure the effectiveness of online initiatives. | Technology Services |
Synageva BioPharma Corp.
Synageva BioPharma Corp. BiotechnologyHealth Technology Synageva BioPharma Corp. is a biopharmaceutical company which focuses on the discovery, development, and commercialization of therapeutic products for patients with life-threatening rare diseases and high unmet medical need. The company is currently evaluating sebelipase alfa in global clinical trials for LAL Deficiency, a lysosomal storage disease associated with liver damage and accelerated atherosclerosis in children and adults, and in infants, premature death often before six months of age. Synageva BioPharma was founded in 1993 and is headquartered in Lexington, MA. | Health Technology |
KSQ Therapeutics, Inc.
KSQ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology KSQ Therapeutics, Inc. develops and deploys precision functional genomics to discover therapies that transform patient lives. The company was founded by Tim Wang and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Christopher Heberlig